Recent
price
P/E
ratio
div
yld
0.19%
ROIC.AI
Warning: STVN is at high risk of performing badly
Q1 2024 Stevanato Group SpA Earnings Call
Italy Based Stevanato Reports Mixed Q1 Earnings, Revises Annual Guidance On Temporary Destocking
Italy Based Stevanato Reports Mixed Q1 Earnings, Revises Annual Guidance On Temporary Destocking
Stevanato Group Reports Financial Results for the First Quarter of 2024
USNA or STVN: Which Is the Better Value Stock Right Now?
Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
Stevanato Group (STVN) to Report Q1 Results: What You Should Expect
Italy’s Frugal Pharma Billionaire Eyes Place Among Global Leaders in Drug Injection Devices
Stevanato Group appoints Ugo Gay as Chief Operations Officer
Stevanato Group appoints Ugo Gay as Chief Operations Officer
Stevanato Group appoints Ugo Gay as Chief Operations Officer
Here’s Why Stevanato (STVN) Declined in Q4
Here’s Why Stevanato Group S.p.A. (STVN) Shares Sold Off in Q4
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.